???pagination.result.count???
???pagination.result.page???
1
Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels. , Twiner MJ., Chem Res Toxicol. September 17, 2012; 25 (9): 1975-84.
Recombinant expression of the toxic peptide ErgTx1 and role of Met35 on its stability and function. , Jimenez-Vargas JM., Peptides. March 1, 2011; 32 (3): 560-7.
Probing the binding sites and mechanisms of action of two human ether-a- go-go-related gene channel activators, 1,3- bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243). , Xu X., Mol Pharmacol. June 1, 2008; 73 (6): 1709-21.
Probing the outer mouth structure of the HERG channel with peptide toxin footprinting and molecular modeling. , Tseng GN., Biophys J. May 15, 2007; 92 (10): 3524-40.
[Electrophysiological characterization of long QT syndrome associated mutations V630A and N633S]. , She HR., Zhonghua Xin Xue Guan Bing Za Zhi. June 1, 2006; 34 (6): 523-7.
Effect of S5P alpha-helix charge mutants on inactivation of hERG K+ channels. , Clarke CE., J Physiol. June 1, 2006; 573 (Pt 2): 291-304.
Structure-function studies of the outer mouth and voltage sensor domain of hERG. , Tseng GN., Novartis Found Symp. January 1, 2005; 266 19-35; discussion 35-45.
Gating charges in the activation and inactivation processes of the HERG channel. , Zhang M., J Gen Physiol. December 1, 2004; 124 (6): 703-18.
Structural and functional role of the extracellular s5-p linker in the HERG potassium channel. , Liu J ., J Gen Physiol. November 1, 2002; 120 (5): 723-37.
Use-dependent 'agonist' effect of azimilide on the HERG channel. , Jiang M., J Pharmacol Exp Ther. December 1, 1999; 291 (3): 1324-36.
Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel. , Fan JS., Biophys J. June 1, 1999; 76 (6): 3128-40.
Regulation of deactivation by an amino terminal domain in human ether-à- go-go-related gene potassium channels. , Wang J ., J Gen Physiol. November 1, 1998; 112 (5): 637-47.
Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation. , Nakajima T., Circ Res. August 24, 1998; 83 (4): 415-22.
Differential effects of bupivacaine on cardiac K channels: role of channel inactivation and subunit composition in drug-channel interaction. , Lipka LJ., J Cardiovasc Electrophysiol. July 1, 1998; 9 (7): 727-42.
Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation. , Wang S., FEBS Lett. November 3, 1997; 417 (1): 43-7.
Molecular determinants for activation and inactivation of HERG, a human inward rectifier potassium channel. , Schönherr R., J Physiol. June 15, 1996; 493 ( Pt 3) 635-42.